PCG
61
2
NEE
42
3
TGT
44
9
MTCH
71
9
ADI
57
2
UNM
70
3
XRX
59
11
SYY
41
-2
EQT
50
3
VZ
22
-2
FDX
33
-11
KR
46
-4
LLY
45
8
AA
31
4
NWS
75
4
DVA
65
3
AON
28
2
BBY
46
-2
TAP
54
-3
PLD
37
2
PCG
61
2
NEE
42
3
TGT
44
9
MTCH
71
9
ADI
57
2
UNM
70
3
XRX
59
11
SYY
41
-2
EQT
50
3
VZ
22
-2
FDX
33
-11
KR
46
-4
LLY
45
8
AA
31
4
NWS
75
4
DVA
65
3
AON
28
2
BBY
46
-2
TAP
54
-3
PLD
37
2
Financhill
Back

Cue Biopharma Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40

CUE
Cue Biopharma

Last Price:
$1.02
Seasonality Move:
-5.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Cue Biopharma Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.03 Buy
20-day SMA: 1.08 Sell
50-day SMA: 1.3 Sell
200-day SMA: 1.26 Sell
8-day EMA: 1.04 Sell
20-day EMA: 1.1 Sell
50-day EMA: 1.15 Sell
200-day EMA: 1.38 Sell

Cue Biopharma Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 43.99 Sell
Chaikin Money Flow: 219222 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.02 - 1.14) Sell
Bollinger Bands (100): (0.63 - 1.39) Buy

Cue Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cue Biopharma Stock

Is Cue Biopharma Stock a Buy?

  • Cue Biopharma share price is 1.04 while CUE 8-day simple moving average is 1.03, which is a Buy signal.
  • The stock price of CUE is 1.04 while Cue Biopharma 20-day SMA is 1.08, which makes it a Sell.
  • Cue Biopharma 50-day simple moving average is 1.30 while CUE share price is 1.04, making it a Sell technically.
  • CUE stock price is 1.04 and Cue Biopharma 200-day simple moving average is 1.26, creating a Sell signal.

CUE Technical Analysis vs Fundamental Analysis

Sell
40
Cue Biopharma (CUE) is a Sell

Is Cue Biopharma a Buy or a Sell?

  • Cue Biopharma stock is rated a Sell
    The current Cue Biopharma [CUE] share price is $1.04. The Score for CUE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.

Cue Biopharma Stock Info

Market Cap:
65.9M
Price in USD:
1.04
Share Volume:
219.2K

Cue Biopharma 52-Week Range

52-Week High:
3.20
52-Week Low:
0.45
Sell
40
Cue Biopharma (CUE) is a Sell

Cue Biopharma Share Price Forecast

  • What is the Cue Biopharma stock price today?
    The Cue Biopharma stock price is 1.04 USD today.
  • Will CUE stock go up or go down?
    Cue Biopharma> share price is forecast to RISE/FALL based on technical indicators
  • Is Cue Biopharma overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cue Biopharma is overvalued.

Is Cue Biopharma Stock a Buy?

  • Cue Biopharma share price is 1.04 while CUE 8-day exponential moving average is 1.04, which is a Sell signal.
  • The stock price of CUE is 1.04 while Cue Biopharma 20-day EMA is 1.10, which makes it a Sell.
  • Cue Biopharma 50-day exponential moving average is 1.15 while CUE share price is 1.04, making it a Sell technically.
  • CUE stock price is 1.04 and Cue Biopharma 200-day simple moving average is 1.38, creating a Sell signal.

Fundamental Analysis of Cue Biopharma

Is Cue Biopharma a good investment?

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.

Technical Analysis of Cue Biopharma

Should I short Cue Biopharma stock?

* Cue Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.